This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Assessment of P-Glycoprotein in Patients with Malignant Bone and Soft-Tissue Tumors Using Technetium-99m-MIBI Scintigraphy
Jump to section
Related Articles
Cited By...
- Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier
- P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of 11C-Metoclopramide Across the Blood-Brain Barrier: A PET Study on Nonhuman Primates
- Usefulness of 99mTc-Sestamibi Scintigraphy in Suggesting the Therapeutic Effect of Chemotherapy against Gastric Cancer
- Predicting the Outcome of Distraction Osteogenesis by 3-Phase Bone Scintigraphy
- Lack of Correlation of Functional Scintigraphy with 99mTechnetium-Methoxyisobutylisonitrile with Histological Necrosis following Induction Chemotherapy or Measures of P-Glycoprotein Expression in High-Grade Osteosarcoma
- 99mTc-MIBI Scintigraphy in Musculoskeletal Tumors